The Clinical Applications of Five-Alpha Reductase Inhibitors
April 2021
in “
Canadian Journal of Urology
”
Studysummary This review summarizes existing studies on 5-alpha reductase inhibitors, noting their effectiveness in reducing prostate volume and cancer risk but highlighting an increased risk of higher grade prostate cancer.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on pubmed.ncbi.nlm.nih.gov →